Angitia Biopharmaceuticals

formerly Angitia

Innovation for Patients

Westlake Village, United States · Founded 2018 · $506.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$506.0M
Last Round
$130.0M Series DFeb 2026
Rounds
8

About

Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing innovative therapeutics for musculoskeletal diseases including osteoporosis, osteogenesis imperfecta, and spinal fusion. The company's pipeline features bispecific antibody candidates in Phase 2 clinical trials, with offices in Westlake Village, California and Guangzhou, China.

Summary

Angitia Biopharmaceuticals is a Biotech company based in Westlake Village, United States, founded in 2018. It has raised $506.0M in total across 8 rounds, most recently a $130.0M Series D round in Feb 2026. Investors include Bain Capital Life Sciences, Morningside Group and Frazier Life Sciences.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series DSeries DFeb 2026
$130.0M

Sign up to see all 8 rounds

Series A through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Angitia Biopharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/angitia-biopharmaceuticals"><img src="https://indexed.vc/api/badge/company/angitia-biopharmaceuticals" alt="Angitia Biopharmaceuticals on Indexed.vc" width="260" height="76" /></a>